Jane Street’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Jane Street’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,000	Closed	-$185K	–	9871
2020 Q4	$185K	Sell	16,000 -7,000	-30%	-$81.3K	﹤0.01%	6989
2020 Q3	$239K	Sell	23,000 -23,600	-51%	-$289K	﹤0.01%	6203
2020 Q2	$613K	Buy	+46,600	New	+$483K	﹤0.01%	4764
2020 Q1	–	Sell	-10,100	Closed	-$209K	–	6260
2019 Q4	$209K	Buy	+10,100	New	+$170K	﹤0.01%	4687
2018 Q2	–	Sell	-10,400	Closed	-$233K	–	5854
2018 Q1	$233K	Buy	+10,400	New	+$254K	﹤0.01%	4297

Jane Street's FLXN Position: Q4 2021 in Review

Jane Street sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 25,108 shares — an estimated $153K sold.

Jane Street first reported a position in FLXN in Q3 2015 and held it in 10 quarters. The position peaked at $1.72M in Q1 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Jane Street reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 25,108 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $153K.
Jane Street first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
Jane Street's Flexion Therapeutics, Inc. position peaked at $1.72M in Q1 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.